
Marijn Dekkers
SlowingNamed in filings at Novalis Lifesciences InvestmentsOn the current fund
- Board seats filed

Named in filings at Novalis Lifesciences InvestmentsOn the current fund
all filings on record
last 24 months
from a verified or cited source
| Flywheel Exchange | Digital health | December 2024 | Rogue |
| Animol Discovery | Biotech & pharma | July 2022 | None on file |
| Vizgen | Biotech & pharma | March 2021 | ARCH Venture Partners |
| Quanterix | Biotech & pharma | March 2016 | ARCH Venture Partners, Bain Capital Ventures, Rogue |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The category is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Categories of companies where filings name Marijn Dekkers on the board, based on 4 filed seats with a verified or cited source.